| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.63 | 0.02 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |